TipRanks
Go Ultimate55% OFF

Cardiol Therapeutics (CRDL) Stock Forecast & Price Target

See the Price Targets and Ratings of:

CRDL Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Cardiol Therapeutics in the past 3 months

CRDL Stock 12 Month Forecast

$10.00▲(861.54% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Cardiol Therapeutics in the last 3 months. The average price target is $10.00 with a high forecast of $11.00 and a low forecast of $9.00. The average price target represents a 861.54% change from the last price of $1.04.
Highest Price Target$11.00Average Price Target$10.00Lowest Price Target$9.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CRDL
Price TargetFollowArticle
Canaccord Genuity$10buy861.54%UpsideReiterated10/28/26
H.C. Wainwright$9buy765.38%UpsideReiterated09/21/26
B. Riley Securities$11buy957.69%UpsideInitiated08/26/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRVITrevi Therapeutics
EHCEncompass Health
MDWDMediwound
OVIDOvid Therapeutics
ONCBeOne Medicines

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardiol Therapeutics

3 Months
Edward Nash
Edward NashCanaccord Genuity
Success Rate10/23 ratings generated profit
43%
Average Return
+1.23%

Copying Edward Nash's trades and holding each position for 3 Months would result in 43.48% of your transactions generating a profit, with an average return of +1.23% per trade.

1 Year
Edward Nash
Edward NashCanaccord Genuity
Success Rate10/23 ratings generated profit
43%
Average Return
+4.91%

Copying Edward Nash's trades and holding each position for 1 Year would result in 43.48% of your transactions generating a profit, with an average return of +4.91% per trade.

2 Years
Brandon Folkes
Brandon FolkesH.C. Wainwright
Success Rate5/12 ratings generated profit
42%
Average Return
-9.41%

Copying Brandon Folkes's trades and holding each position for 2 Years would result in 41.67% of your transactions generating a profit, with an average return of -9.41% per trade.

CRDL Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for CRDL
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy55784
Buy00000
Hold00000
Sell00000
Strong Sell00000
total55784

In the current month, CRDL has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CRDL average Analyst price target in the past 3 months is 10.00.

CRDL Financial Forecast

$-2$-1.5$-1$-0.5$0Q3 2025Q2 2026Q3 2026
High$-0.05
Consensus$-0.06
Low$-0.08

CRDL Earnings Forecast

Next quarter’s earnings estimate for CRDL is -$0.06 with a range of -$0.08 to -$0.05. The previous quarter’s EPS was -$0.04. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q3 2025Q2 2026Q3 2026
High$0.00
Consensus$0.00
Low$0.00

CRDL Sales Forecast

Next quarter’s sales forecast for CRDL is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

CRDL Stock Forecast FAQ

What is CRDL’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardiol Therapeutics’s 12-month average price target is $10.00.
What is CRDL’s upside potential, based on the analysts’ average price target?
Cardiol Therapeutics has 861.54% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRDL a Buy, Sell or Hold?
Cardiol Therapeutics has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Cardiol Therapeutics’s price target?
The average price target for Cardiol Therapeutics is $10.00. This is based on 3 12-month price targets, issued in the past 3 months. The highest analyst price target is $11.00, the lowest forecast is $9.00. The average price target represents a 861.54% increase from the current price of $1.04.
What do analysts say about Cardiol Therapeutics?
Cardiol Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of CRDL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.